Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion type Assertion NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_head.
- NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion description "[Compared with `alcoholic` controls without liver disease (n=110), TNF? -238AA genotype, IL1? -511CC genotype, TGF?1 -509CC genotype and IL10 -592AA genotype were significantly overrepresented in ALD patients (n=181; OR=2.4 and 95% CI 1.2-5.5, P(genotype)=0.042, P(allelic)=0.008; OR=2.7 and 95% CI 1.2-5.9, P(genotype)=0.018, P(allelic)=0.023; OR=4.7 and 95% CI 1.7-13.1, P(genotype)=0.003, P(allelic)=0.014; and OR=2.2 and 95% CI 1.1-4.8, P(genotype)=0.04, P(allelic)=0.039 respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_provenance.
- NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion evidence source_evidence_literature NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_provenance.
- NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion SIO_000772 22902304 NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_provenance.
- NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion wasDerivedFrom befree-20140225 NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_provenance.
- NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_assertion wasGeneratedBy ECO_0000203 NP432802.RAL96PrOw41GUkLjn5pHJHDEAEDUhhNuG9FzUT7fb37pQ130_provenance.